Shelter Pharma Ltd.

26.90-0.1 (-0.37%)

24 Jul, 12:00 AM

Income Statement

Abridged

Understanding Income Statement

Shelter Pharma Ltd. income statement covering revenue, operating profit, EBITDA, PAT and EPS across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31

Period length: Source:	12M PR	12M PR	12M PR	12M IR	12M AR	12M AR	12M PRESS
Total Revenue	30.07	22.48	30.06	36.15	40.02	50.66	73.13
Cost of Operating Revenue	28.43	21.26	26.02	26.42	29.15	37.30	55.98
Gross Profit	1.63	1.23	4.04	9.74	10.87	13.36	17.15
Gross Margin	5.4	5.5	13.4	26.9	27.2	26.4	23.5
Total Operating Expenses	29.96	22.43	27.25	28.26	31.68	40.86	60.82
Operating Profit	0.10	0.06	2.81	7.89	8.34	9.80	12.32
Operating Margin	0.3	0.3	9.3	21.8	20.8	19.3	16.8
Financing Income/(Expense) - Net	-	-	-0.01	-0.01	-0.05	-0.13	-0.11
Profit before Taxes	0.11	0.06	2.81	6.98	8.28	9.68	12.22
Income Taxes	0.03	0.02	0.75	1.78	2.08	2.44	3.20
Profit after Tax	0.08	0.04	2.06	5.21	6.20	7.24	9.03
PAT Margin	0.3	0.2	6.9	14.4	15.5	14.3	12.3
EPS - Basic - ex Extraordinary Items	0.07	0.04	1.78	4.50	5.36	6.26	6.57
EPS - Diluted - ex Extraordinary Items	0.07	0.04	1.78	4.50	5.36	6.26	5.16
EBIT	0.10	0.06	2.81	7.89	8.34	9.80	12.32
EBITDA	0.23	0.17	2.98	8.06	8.59	10.07	12.73
EBITDA Margin	0.8	0.8	9.9	22.3	21.5	19.9	17.4

Balance Sheet

Abridged

Understanding Balance Sheet

Shelter Pharma Ltd. balance sheet covering assets, liabilities, equity and borrowings across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31

Source:	PR	PR	PR	IR	AR	AR	PRESS
Total Current Assets	8.07	7.88	9.83	18.72	29.72	33.28	55.05
Long-Term Investments	0.68	0.68	0.68	0.68	0.68	0.68	0.68
Property Plant & Equipment - Net	1.77	1.57	2.00	1.85	3.57	5.95	6.68
Total Non-Current Assets	2.57	2.32	3.01	2.73	8.20	15.06	29.18
Total Assets	10.63	10.20	12.84	21.45	37.91	48.34	84.23
Total Current Liabilities	3.47	2.90	3.83	6.25	1.47	4.63	7.00
Long Term Debt	-	-	0.06	0.48	0.57	0.93	0.53
Total Non-Current Liabilities	0.18	0.19	0.20	0.65	0.62	0.99	0.60
Total Liabilities	3.65	3.09	4.04	6.90	2.10	5.61	7.60
Total Shareholders' Equity	6.98	7.11	8.80	14.55	35.82	42.72	76.63
Total Equity	6.98	7.11	8.80	14.55	35.82	42.72	76.63
Total Liabilities & Equity	10.63	10.20	12.84	21.45	37.91	48.34	84.23

Cash Flow

Abridged

Understanding Cash Flow Statement

Shelter Pharma Ltd. cash flow statement covering operating, investing and financing activities across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31

Period length: Source:	12M PR	12M PR	12M PR	12M IR	12M AR	12M AR	12M PRESS
Operating CF bef Changes in Working Cap	-0.07	-0.11	2.55	7.23	7.41	7.51	9.42
Working Capital - Increase/(Decrease)	-0.28	0.07	-2.10	-9.36	-7.96	-2.13	-21.88
Net CF from Operating Activities	-0.35	-0.05	0.46	-2.13	-0.55	5.38	-12.46
Capital Expenditures - Net	0.05	0.01	0.60	0.00	0.85	2.65	1.59
Net CF from Investing Activities	0.29	0.03	-0.85	0.11	-4.55	-7.13	-14.57
Dividends Paid - Cash - Total	-	-	-	-	-	0.38	0.38
Stock - Issuance/(Retirement) - Net	-	0.48	-	-0.20	10.91	-	25.31
Debt - LT & ST - Issuance/(Retirement) - Total	0.08	-0.23	0.13	1.65	-1.21	0.47	-0.24
Net Cash Flow from Financing Activities	0.08	0.25	0.13	1.45	9.71	0.13	24.69
Free Cash Flow to Equity	-0.32	-0.29	-0.02	-0.49	-2.61	3.20	-14.30
Free Operating CF net dividend	-0.40	-0.06	-0.15	-2.14	-1.40	2.35	-14.43
Free Operating CF	-0.40	-0.06	-0.15	-2.14	-1.40	2.73	-14.05

Business Segment Analysis

Shelter Pharma Ltd. business segment breakdown covering revenue, operating income and assets across key divisions for the selected financial year.

We don't have enough data to show business segment analysis for Shelter Pharma Ltd.

Regional Segment Analysis

Shelter Pharma Ltd. geographic revenue split showing domestic and international market performance across revenue and income for the selected financial year.

We don't have enough data to show regional segment analysis for Shelter Pharma Ltd.

Historical Segment Analysis

Track how Shelter Pharma Ltd. segment contributions have evolved over multiple financial years to see which divisions are growing, shrinking or gaining strategic importance.

We don't have enough data to show segments for Shelter Pharma Ltd.

Frequently Asked Questions

What is the revenue of Shelter Pharma Ltd.?

The latest trailing twelve month revenue of Shelter Pharma Ltd. is ₹ 73.13 Cr, reflecting a 1-year growth of 44.36% and a 3-year CAGR of 26.47%. Annual and quarterly revenue trends are available in the Income Statement section.

What is the net profit of Shelter Pharma Ltd.?

The latest trailing twelve month net profit (PAT) of Shelter Pharma Ltd. is ₹ 9.03 Cr, with a 3-year earnings CAGR of 4.67%. Detailed profit history across annual and quarterly periods is in the Income Statement section.

What is the EBITDA of Shelter Pharma Ltd.?

The trailing twelve month EBITDA of Shelter Pharma Ltd. is approximately ₹ 12.32 Cr (based on an operating margin of 16.84%). EBITDA reflects core operating profitability before interest, taxes, depreciation and amortisation.

What is the EPS of Shelter Pharma Ltd.?

The trailing twelve month Earnings Per Share (EPS) of Shelter Pharma Ltd. is 5.16. EPS trends across annual and quarterly periods are visible in the Income Statement section.

What is the debt level of Shelter Pharma Ltd.?

The debt-to-equity ratio of Shelter Pharma Ltd. stands at 0.01. The interest coverage ratio is 114.46x, reflecting the company's ability to service debt from operating earnings. The full breakdown of total borrowings is in the Balance Sheet section.

What is the book value per share of Shelter Pharma Ltd.?

The estimated book value per share of Shelter Pharma Ltd. is 45.51 (derived from a P/B ratio of 0.59 and market price of ₹ 26.90), reflecting the net asset value attributable to each share. See the Balance Sheet section for a full breakdown.

What is the cash flow from operations of Shelter Pharma Ltd.?

The trailing twelve month operating cash flow of Shelter Pharma Ltd. is ₹ -12.46 Cr. Annual and quarterly cash flow data is available in the Cash Flow section of the Statements tab.

Does Shelter Pharma Ltd. report consolidated or standalone financials?

Shelter Pharma Ltd. reports consolidated financials. You can toggle between consolidated and standalone views using the switch at the top of each statement section.